V BRYAN LAWLIS Insider Trading $BMRN BIOMARIN PHARMACEUTICAL INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for V BRYAN LAWLIS.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of V BRYAN LAWLIS. V BRYAN LAWLIS is President in ARADIGM CORP ($ARDM) and Director in GERON CORP ($GERN) and Director in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in SUTRO BIOPHARMA INC ($STRO) and Director in Coherus BioSciences, Inc. ($CHRS) and Director in Aeglea BioTherapeutics, Inc. ($AGLE).

V BRYAN LAWLIS in BIOMARIN PHARMACEUTICAL INC

Trading Symbol: BMRN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of V BRYAN LAWLIS: Director
Holdings: 23,970 shares
Current Value: $2,131,173
Latest Transaction: May 27 2021
$BMRN Market Capitalization: $15.63B
$BMRN Previous Close: $88.91

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of V BRYAN LAWLIS in BIOMARIN PHARMACEUTICAL INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AGLE, ARDM, BMRN, CHRS, GERN, STRO

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 27 2021BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorGrantA0.005,120023,97018.9 K to 24 K (+27.16 %)
Apr 19 2021BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorOption ExerciseM26.497,500198,6750
Apr 19 2021BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorSellS76.907,500576,75018,85026.4 K to 18.9 K (-28.46 %)
Apr 19 2021BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorBuyM26.497,500198,67526,35018.9 K to 26.4 K (+39.79 %)
Jun 09 2020BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorSellS107.464,430476,04818,85023.3 K to 18.9 K (-19.03 %)
May 29 2020BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorGrantA0.004,300023,28019 K to 23.3 K (+22.66 %)
Mar 18 2020BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorOption ExerciseM21.513,75080,6630
Mar 18 2020BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorSellS75.393,750282,71318,98022.7 K to 19 K (-16.50 %)
Mar 18 2020BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorBuyM21.513,75080,66322,73019 K to 22.7 K (+19.76 %)
Mar 18 2020BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorSellS76.524,610352,75718,98023.6 K to 19 K (-19.54 %)
Dec 19 2019BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorOption ExerciseM21.513,75080,6633,750
Dec 19 2019BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorSellS83.363,750312,60023,59027.3 K to 23.6 K (-13.72 %)
Dec 19 2019BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorBuyM21.513,75080,66327,34023.6 K to 27.3 K (+15.90 %)
Sep 18 2019BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorOption ExerciseM21.513,75080,6637,500
Sep 18 2019BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorSellS74.473,750279,26323,59027.3 K to 23.6 K (-13.72 %)
Sep 18 2019BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorBuyM21.513,75080,66327,34023.6 K to 27.3 K (+15.90 %)
Jun 19 2019BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorOption ExerciseM21.513,75080,66311,250
Jun 19 2019BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorSellS81.083,750304,05023,59027.3 K to 23.6 K (-13.72 %)
Jun 19 2019BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorBuyM21.513,75080,66327,34023.6 K to 27.3 K (+15.90 %)
Jun 06 2019BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorGrantA0.004,430023,59019.2 K to 23.6 K (+23.12 %)
Mar 29 2019BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorOption ExerciseM14.392,15030,9390
Mar 29 2019BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorSellS89.762,150192,98419,16021.3 K to 19.2 K (-10.09 %)
Mar 29 2019BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorBuyM14.392,15030,93921,31019.2 K to 21.3 K (+11.22 %)
Dec 28 2018BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorOption ExerciseM14.392,15030,9392,150
Dec 28 2018BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorSellS82.532,150177,44019,16021.3 K to 19.2 K (-10.09 %)
Dec 28 2018BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorBuyM14.392,15030,93921,31019.2 K to 21.3 K (+11.22 %)
Sep 28 2018BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorOption ExerciseM14.392,15030,9394,300
Sep 28 2018BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorSellS97.932,150210,55019,16021.3 K to 19.2 K (-10.09 %)
Sep 28 2018BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorBuyM14.392,15030,93921,31019.2 K to 21.3 K (+11.22 %)
Jun 29 2018BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorOption ExerciseM14.392,15030,9396,450
Jun 29 2018BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorSellS93.522,150201,06819,16021.3 K to 19.2 K (-10.09 %)
Jun 29 2018BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorBuyM14.392,15030,93921,31019.2 K to 21.3 K (+11.22 %)
Jun 07 2018BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorGrantA0.004,300019,16014.9 K to 19.2 K (+28.94 %)
Apr 19 2018BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorOption ExerciseM38.593,750144,7130
Apr 19 2018BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorSellS85.003,750318,75014,86018.6 K to 14.9 K (-20.15 %)
Apr 19 2018BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorBuyM38.593,750144,71318,61014.9 K to 18.6 K (+25.24 %)
Jan 04 2018BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorOption ExerciseM38.593,750144,7133,750
Jan 04 2018BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorSellS88.843,750333,15014,86018.6 K to 14.9 K (-20.15 %)
Jan 04 2018BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorBuyM38.593,750144,71318,61014.9 K to 18.6 K (+25.24 %)
Sep 19 2017BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorOption ExerciseM38.593,750144,7137,500
Sep 19 2017BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorSellS91.263,750342,22515,91019.7 K to 15.9 K (-19.07 %)
Sep 19 2017BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorBuyM38.593,750144,71319,66015.9 K to 19.7 K (+23.57 %)
Jun 20 2017BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorOption ExerciseM38.593,750144,71311,250
Jun 20 2017BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorSellS90.003,750337,50015,91019.7 K to 15.9 K (-19.07 %)
Jun 20 2017BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorBuyM38.593,750144,71319,66015.9 K to 19.7 K (+23.57 %)
Jun 08 2017BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorOption ExerciseA89.604,910439,9364,910
Jun 08 2017BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorGrantA0.002,050015,91013.9 K to 15.9 K (+14.79 %)
Nov 14 2016BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorOption ExerciseM17.337,500129,9757,500
Nov 14 2016BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorSellS95.007,500712,50013,86021.4 K to 13.9 K (-35.11 %)
Nov 14 2016BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorBuyM17.337,500129,97521,36013.9 K to 21.4 K (+54.11 %)
Jul 28 2016BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorOption ExerciseM17.331,10019,06315,000
Jul 28 2016BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorSellS95.391,100104,92713,86015 K to 13.9 K (-7.35 %)
Jul 28 2016BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorBuyM17.331,10019,06314,96013.9 K to 15 K (+7.94 %)
Jul 26 2016BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorOption ExerciseM17.336,400110,91216,100
Jul 26 2016BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorSellS95.016,400608,06413,86020.3 K to 13.9 K (-31.59 %)
Jul 26 2016BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorBuyM17.336,400110,91220,26013.9 K to 20.3 K (+46.18 %)
Jun 21 2016BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorSellS82.7755045,52413,86014.4 K to 13.9 K (-3.82 %)
Jun 08 2016BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorOption ExerciseA89.524,440397,4694,440
Jun 08 2016BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorGrantA0.001,510014,41012.9 K to 14.4 K (+11.71 %)
Nov 18 2015BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorOption ExerciseM17.337,500129,97522,500
Nov 18 2015BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorBuyS107.277,500804,53011,8504.4 K to 11.9 K (+172.41 %)
Nov 18 2015BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorBuyM17.337,500129,97519,35011.9 K to 19.4 K (+63.29 %)
Nov 18 2015BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorSellS104.261,050109,46811,85012.9 K to 11.9 K (-8.14 %)
Jun 18 2015BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorOption ExerciseA122.273,300403,4913,300
Jun 18 2015BMRNBIOMARIN PHARMACEU ...LAWLIS V BRYANDirectorGrantA0.001,100012,90011.8 K to 12.9 K (+9.32 %)

Page:   1